Cited by 191Cholangiocarcinoma and Gallbladder Cancer StudiesPediatric Hepatobiliary Diseases and TreatmentsGallbladder and Bile Duct Disorders

Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease

Open access
Ethun, Cecilia G., Lopez-Aguiar, Alexandra G., Anderson, Douglas J., Adams, Andrew B., Fields, Ryan C., Doyle, Maria B., Chapman, William C., Krasnick, Bradley A. +18 more·2018·Annals of Surgery

Abstract

Objective: To investigate the influence of type of surgery (transplant vs resection) on overall survival (OS) in patients with hilar cholangiocarcinoma (H-CCA). Background: Outcomes after resection for H-CCA are poor, yet transplantation is currently only reserved for well-selected patients with unresectable disease. Methods: All patients with H-CCA who underwent resection from 2000 to 2015 at 10 institutions were included. Three institutions additionally had active H-CCA transplant protocols with similar selection criteria over similar time periods. Results: Of 304 patients with suspected H-CCA, 234 underwent attempted resection and 70 were enrolled in a transplant protocol. Excluding incomplete/R2 resections (n = 43), patients who were enrolled, but did not undergo transplant (n = 24), and transplants without confirmed H-CCA diagnoses (n = 5), 191 patients underwent curative-intent resection and 41 curative-intent transplant. Compared with resection, transplant patients were younger (52 vs 65 years; P < 0.001), and more frequently had primary sclerosing cholangitis (PSC; 61% vs 2%; P < 0.001) and received chemotherapy and/or radiation (98% vs 57%; P < 0.001). Groups were otherwise similar in demographics and comorbidities. Patients who underwent transplant for confirmed H-CCA diagnosis had improved OS compared with resection (3-year: 72% vs 33%; 5-year: 64% vs 18%; P < 0.001). Among patients who underwent resection for tumors <3 cm with lymph-node negative disease, and excluding PSC patients, transplant was still associated with improved OS (3-year: 54% vs 44%; 5-year: 54% vs 29%; P = 0.03). Transplant remained associated with improved survival on intention-to-treat analysis, even after accounting for tumor size, lymph node status, and PSC ( P = 0.049). Conclusions: Resection for hilar cholangiocarcinoma that meets criteria for transplantation (<3 cm, lymph-node negative disease) is associated with substantially decreased survival compared to transplant for the same criteria with unresectable disease. Prospective trials are needed and justified.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/sla.0000000000002574

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Liver transplantation is associated with better long-term outcomes than resection for hilar CCA.

    “However, liver transplantation is a potentially curative treatment option and has been reported to be associated with better long-term outcomes than resection for hilar CCA.334,335”

    From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [335]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [23]Intrahepatic Bile Ducts Edge SB Byrd DR Compton CC Fritz AG Greene FL T A III AJCC Cancer Staging Manual 7th New York Springer 2010 201 209

Cited by

Sorted by citations

Authors
Ethun, C. G., Lopez-Aguiar, A. G., Anderson, D. J., Adams, A. B., Fields, R. C., Doyle, M. B., Chapman, W. C., Krasnick, B. A., Weber, S. M., Mezrich, J. D., Salem, A., Pawlik, T. M., Poultsides, G., Tran, T. B., Idrees, K., Isom, C. A., Martin, R. C. G., Scoggins, C. R., Shen, P., Mogal, H. D., Schmidt, C., Beal, E., Hatzaras, I., Shenoy, R., Cardona, K., & Maithel, S. K.
Affiliations
  • Emory University (US)
  • Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, GA
  • Washington University in St. Louis (US)
  • University of Wisconsin–Madison (US)
  • Johns Hopkins University (US)
  • University of Louisville (US)
  • The Ohio State University (US)
Corresponding author
  • Ethun, Cecilia G.
  • Pawlik, Timothy M.
  • Hatzaras, Ioannis
  • Shenoy, Rivfka
  • Cardona, Kenneth
  • Maithel, Shishir K.
Venue
Annals of Surgery
Published
2018-05
Volume
267
Issue
5
Pages
797-805
ISSN
  • 0003-4932 (ISSN-L)
  • 1528-1140
OpenAlex
W2766326448
Cited by
191
References
28
Citations by year
2026: 10 · 2025: 25 · 2024: 25 · 2023: 22 · 2022: 21 · 2021: 27 · 2020: 30 · 2019: 20 · 2018: 9 · 2017: 1
FWCI
16.80
Type
journal article
Language
en
Open access
Locations
  • Annals of Surgery (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Cancer Institute (K12CA090625, T32CA009621, T32CA106183, P30CA016058, P30CA091842)
Topics
  • Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Gallbladder and Bile Duct Disorders
Keywords
hilar cholangiocarcinoma, liver transplantation, hepatectomy, surgical resection, overall survival, primary sclerosing cholangitis, unresectable disease, lymph node status, tumor size, curative-intent surgery
MeSH terms
Adult, Aged, Bile Duct Neoplasms, Bile Ducts, Intrahepatic, Female, Follow-Up Studies, Hepatectomy, Humans, Male, Middle Aged, Retrospective Studies, United States, Survival Rate, Liver Transplantation, Klatskin Tumor, Patient Selection

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review